Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target
Open Access
- 20 March 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (7) , 1-20
Abstract
YARS is responsible for catalysing the binding of tyrosine to its cognate tRNA and plays a crucial role in basic biosynthesis. However, its biological functions in bladder cancer remains to be proven. We analysed variations in YARS1 expression and survival in bladder cancer using multiple data sets, including TCGA‐BLCA, GSE13507 and bladder cancer‐specific tissue microarrays. Furthermore, we explored the biological functions of YARS1 using transcriptome data. Our findings revealed a noteworthy correlation between YARS1 and immune infiltration in bladder cancer, as determined using the XCELL algorithm and single‐cell analysis. In addition, we employed the TIDE algorithm to evaluate the responsiveness of different cohorts to immune checkpoint therapy. We investigated the regulatory associations between YARS1 and various aspects of bladder cancer, including senescence, ferroptosis and stemness. Finally, we established a ceRNA network that is directly linked to the overall prognosis, YARS1 can serve as a prognostic biomarker for bladder cancer; its interaction with MYC has implications for bladder cancer cell senescence, ferroptosis and stemness. Moreover, the identified ceRNA network has potential as a therapeutic target in bladder cancer.Keywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (LH2019H030)
- National Natural Science Foundation of China (82002680)
This publication has 39 references indexed in Scilit:
- Senescence-associated reprogramming promotes cancer stemnessNature, 2017
- DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactionsNucleic Acids Research, 2017
- MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinomaBritish Journal of Cancer, 2017
- Tyrosyl-tRNA synthetase inhibitors: a patent reviewExpert Opinion on Therapeutic Patents, 2017
- Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex NeuropathyCell Reports, 2015
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq dataNucleic Acids Research, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathyNature Genetics, 2006
- COGNITION, MECHANISM, AND EVOLUTIONARY RELATIONSHIPS IN AMINOACYL-tRNA SYNTHETASESAnnual Review of Biochemistry, 1993